Plasma immunoglobulin binding protein 1 as a predictor of development of lupus nephritis
Objective Urine levels of immunoglobulin binding protein 1 (IGBP1) are increased in patients with lupus nephritis (LN) compared with systemic lupus erythematosus (SLE) patients without nephritis. However, the clinical significance of IGBP1 level in plasma is unclear. We aimed to evaluate whether the...
Saved in:
Published in | Lupus Vol. 29; no. 6; pp. 547 - 553 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.05.2020
Sage Publications Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
Urine levels of immunoglobulin binding protein 1 (IGBP1) are increased in patients with lupus nephritis (LN) compared with systemic lupus erythematosus (SLE) patients without nephritis. However, the clinical significance of IGBP1 level in plasma is unclear. We aimed to evaluate whether the plasma level of IGBP1 can predict future development of LN in SLE patients without nephritis.
Methods
Forty-three SLE patients without nephritis were followed for 5 years. Plasma IGBP1 levels were measured using ELISA, and clinical and laboratory data were obtained at study entry. Development of LN was confirmed by renal biopsy. Cox regression analysis was performed to identify factors associated with development of LN, and receiver operating characteristic curve analysis was used to determine the predictive value of each factor.
Results
Of the total 43 patients, eight (18.6%) developed LN during the follow-up period. Compared with patients who did not develop LN, those who developed LN had higher levels of plasma IGBP1 (6.3 ng/ml (range 4.3–9.6 ng/mL) vs. 13.3 ng/ml (range 7.2–31.3 ng/ml); p = 0.023). In the Cox regression analysis, higher CRP (hazard ratio (HR) = 1.325, 95% confidence interval (CI) 1.073–1.637, p = 0.009), anti-dsDNA antibody (Ab; HR = 1.066, 95% CI 1.012–1.124, p = 0.017) and plasma IGBP1 (HR = 1.091, 95% CI 1.034–1.152, p = 0.002) were associated with future development of LN. Among these factors, anti-dsDNA Ab (area under the curve (AUC)=0.893) had the highest predictive value followed by plasma IGBP1 (AUC = 0.761) and CRP (AUC = 0.634). A combination of anti-dsDNA Ab and plasma IGBP1 as a composite predictor was highly specific (97%) for predicting the development of LN.
Conclusions
Plasma IGBP1 can be used complementarily with anti-dsDNA Ab for detecting SLE patients at a higher risk of developing LN. |
---|---|
AbstractList | ObjectiveUrine levels of immunoglobulin binding protein 1 (IGBP1) are increased in patients with lupus nephritis (LN) compared with systemic lupus erythematosus (SLE) patients without nephritis. However, the clinical significance of IGBP1 level in plasma is unclear. We aimed to evaluate whether the plasma level of IGBP1 can predict future development of LN in SLE patients without nephritis. MethodsForty-three SLE patients without nephritis were followed for 5 years. Plasma IGBP1 levels were measured using ELISA, and clinical and laboratory data were obtained at study entry. Development of LN was confirmed by renal biopsy. Cox regression analysis was performed to identify factors associated with development of LN, and receiver operating characteristic curve analysis was used to determine the predictive value of each factor. ResultsOf the total 43 patients, eight (18.6%) developed LN during the follow-up period. Compared with patients who did not develop LN, those who developed LN had higher levels of plasma IGBP1 (6.3 ng/ml (range 4.3–9.6 ng/mL) vs. 13.3 ng/ml (range 7.2–31.3 ng/ml); p=0.023). In the Cox regression analysis, higher CRP (hazard ratio (HR)=1.325, 95% confidence interval (CI) 1.073–1.637, p=0.009), anti-dsDNA antibody (Ab; HR=1.066, 95% CI 1.012–1.124, p=0.017) and plasma IGBP1 (HR=1.091, 95% CI 1.034–1.152, p=0.002) were associated with future development of LN. Among these factors, anti-dsDNA Ab (area under the curve (AUC)=0.893) had the highest predictive value followed by plasma IGBP1 (AUC=0.761) and CRP (AUC=0.634). A combination of anti-dsDNA Ab and plasma IGBP1 as a composite predictor was highly specific (97%) for predicting the development of LN. ConclusionsPlasma IGBP1 can be used complementarily with anti-dsDNA Ab for detecting SLE patients at a higher risk of developing LN. Objective Urine levels of immunoglobulin binding protein 1 (IGBP1) are increased in patients with lupus nephritis (LN) compared with systemic lupus erythematosus (SLE) patients without nephritis. However, the clinical significance of IGBP1 level in plasma is unclear. We aimed to evaluate whether the plasma level of IGBP1 can predict future development of LN in SLE patients without nephritis. Methods Forty-three SLE patients without nephritis were followed for 5 years. Plasma IGBP1 levels were measured using ELISA, and clinical and laboratory data were obtained at study entry. Development of LN was confirmed by renal biopsy. Cox regression analysis was performed to identify factors associated with development of LN, and receiver operating characteristic curve analysis was used to determine the predictive value of each factor. Results Of the total 43 patients, eight (18.6%) developed LN during the follow-up period. Compared with patients who did not develop LN, those who developed LN had higher levels of plasma IGBP1 (6.3 ng/ml (range 4.3–9.6 ng/mL) vs. 13.3 ng/ml (range 7.2–31.3 ng/ml); p = 0.023). In the Cox regression analysis, higher CRP (hazard ratio (HR) = 1.325, 95% confidence interval (CI) 1.073–1.637, p = 0.009), anti-dsDNA antibody (Ab; HR = 1.066, 95% CI 1.012–1.124, p = 0.017) and plasma IGBP1 (HR = 1.091, 95% CI 1.034–1.152, p = 0.002) were associated with future development of LN. Among these factors, anti-dsDNA Ab (area under the curve (AUC)=0.893) had the highest predictive value followed by plasma IGBP1 (AUC = 0.761) and CRP (AUC = 0.634). A combination of anti-dsDNA Ab and plasma IGBP1 as a composite predictor was highly specific (97%) for predicting the development of LN. Conclusions Plasma IGBP1 can be used complementarily with anti-dsDNA Ab for detecting SLE patients at a higher risk of developing LN. Urine levels of immunoglobulin binding protein 1 (IGBP1) are increased in patients with lupus nephritis (LN) compared with systemic lupus erythematosus (SLE) patients without nephritis. However, the clinical significance of IGBP1 level in plasma is unclear. We aimed to evaluate whether the plasma level of IGBP1 can predict future development of LN in SLE patients without nephritis. Forty-three SLE patients without nephritis were followed for 5 years. Plasma IGBP1 levels were measured using ELISA, and clinical and laboratory data were obtained at study entry. Development of LN was confirmed by renal biopsy. Cox regression analysis was performed to identify factors associated with development of LN, and receiver operating characteristic curve analysis was used to determine the predictive value of each factor. Of the total 43 patients, eight (18.6%) developed LN during the follow-up period. Compared with patients who did not develop LN, those who developed LN had higher levels of plasma IGBP1 (6.3 ng/ml (range 4.3–9.6 ng/mL) vs. 13.3 ng/ml (range 7.2–31.3 ng/ml); p=0.023). In the Cox regression analysis, higher CRP (hazard ratio (HR)=1.325, 95% confidence interval (CI) 1.073–1.637, p=0.009), anti-dsDNA antibody (Ab; HR=1.066, 95% CI 1.012–1.124, p=0.017) and plasma IGBP1 (HR=1.091, 95% CI 1.034–1.152, p=0.002) were associated with future development of LN. Among these factors, anti-dsDNA Ab (area under the curve (AUC)=0.893) had the highest predictive value followed by plasma IGBP1 (AUC=0.761) and CRP (AUC=0.634). A combination of anti-dsDNA Ab and plasma IGBP1 as a composite predictor was highly specific (97%) for predicting the development of LN. Plasma IGBP1 can be used complementarily with anti-dsDNA Ab for detecting SLE patients at a higher risk of developing LN. |
Author | Oh, Ji Seon Kim, Yong-Gil Lee, Eun-Ju Lee, Chang-Keun Kwon, Oh Chan Park, Min-Chan Yoo, Bin Hong, Seokchan |
Author_xml | – sequence: 1 givenname: Oh Chan surname: Kwon fullname: Kwon, Oh Chan – sequence: 2 givenname: Eun-Ju surname: Lee fullname: Lee, Eun-Ju – sequence: 3 givenname: Ji Seon surname: Oh fullname: Oh, Ji Seon – sequence: 4 givenname: Seokchan orcidid: 0000-0001-8722-3124 surname: Hong fullname: Hong, Seokchan – sequence: 5 givenname: Chang-Keun surname: Lee fullname: Lee, Chang-Keun – sequence: 6 givenname: Bin surname: Yoo fullname: Yoo, Bin – sequence: 7 givenname: Min-Chan orcidid: 0000-0003-1189-7637 surname: Park fullname: Park, Min-Chan – sequence: 8 givenname: Yong-Gil orcidid: 0000-0002-8029-7355 surname: Kim fullname: Kim, Yong-Gil |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32183589$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kMFL5TAQxoO46NPduycpePFSnTRJmx5FdBUEPazgrUzTydtIm9SmFfzvzeO5Kwiehm_mN98M3wHb9cETY0cczjivqnOoS16AEAXUvBCi3GErLqsqT_1il60243wz32cHMT4DgOB1ucf2RcG1ULpesaeHHuOAmRuGxYd1H9qldz5rne-cX2fjFGZKmmcYM0ySOmfmMGXBZh29Uh_Ggfy8kf0yLjHzNP6d3OziT_bDYh_p10c9ZI_XV38ub_K7-9-3lxd3uRGlmnOpAEl2UFlh0VYWsJNY6g5tK401QAWaQpHWpIxBocEYjQrAKIltZYQ4ZKdb3_Tqy0JxbgYXDfU9egpLbApRaa2VlCqhJ1_Q57BMPn2XqFqC0iWHRMGWMlOIcSLbjJMbcHprODSb1JuvqaeV4w_jpR2o-7_wL-YE5Fsg4po-r35r-A7CX4ws |
CitedBy_id | crossref_primary_10_3390_jcm11195759 crossref_primary_10_1097_BOR_0000000000000862 crossref_primary_10_1186_s40246_023_00513_4 crossref_primary_10_1177_09612033221141278 |
Cites_doi | 10.1016/j.semarthrit.2018.02.012 10.1016/j.molcel.2009.09.025 10.1074/jbc.M110.166785 10.11613/BM.2016.034 10.1177/0961203315570162 10.1093/rheumatology/kem154 10.1016/S0140-6736(14)60128-8 10.1074/jbc.M113.483743 10.1136/ard.62.5.435 10.4049/jimmunol.152.6.2742 10.1016/S0014-5793(99)00189-1 10.1172/JCI24895 10.4049/jimmunol.181.5.3658 10.4049/jimmunol.1200143 10.1002/art.21955 10.1002/acr.21664 10.1002/art.1780400928 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 |
Copyright_xml | – notice: The Author(s) 2020 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 K9. 7X8 |
DOI | 10.1177/0961203320912336 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1477-0962 |
EndPage | 553 |
ExternalDocumentID | 10_1177_0961203320912336 32183589 10.1177_0961203320912336 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -MK -TM .2E .2F .2G .2J .2N .GJ 01A 0R~ 18M 1~K 29L 31R 31S 31U 31X 31Y 31Z 36B 39C 3V. 4.4 53G 54M 5GY 5VS 7X7 88E 8FI 8FJ 8R4 8R5 AABMB AABOD AACKU AACMV AACTG AADTT AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAKGS AAMGE AANSI AAPEO AAQDB AAQXH AARDL AARIX AATAA AATBZ AAUAS AAXOT AAYTG AAZBJ ABAFQ ABAWP ABCCA ABDBF ABDWY ABEIX ABFWQ ABHKI ABHQH ABJIS ABKRH ABLUO ABOCM ABPGX ABPNF ABQKF ABQXT ABRHV ABUWG ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJTF ACLFY ACLHI ACLZU ACOFE ACOXC ACPRK ACROE ACSBE ACSIQ ACTQU ACUAV ACUIR ACXKE ACXMB ADBBV ADEIA ADMPF ADNBR ADRRZ ADTBJ ADUCT ADUKL ADZZY AECGH AECVZ AEDTQ AEGXH AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEUIJ AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFOSN AFQAA AFUIA AGKLV AGNHF AGWFA AHMBA AIAGR AIGRN AIOMO AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ ALIPV ALJHS ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AUVAJ AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKIIM BKNYI BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD BYIEH C45 CBRKF CCPQU CDWPY CFDXU CORYS CQQTX CS3 CUTAK DB0 DC- DC0 DD- DD0 DE- DF0 DO- DOPDO DU5 DV7 DV9 D~Y EAD EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P FEDTE FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION HF~ HMCUK HVGLF HZ~ J8X JCYGO K.F K.J K9- M0R M1P M4V N9A O9- OVD P.B P2P PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM SV3 TEORI TUS UKHRP ZONMY ZPPRI ZRKOI ZSSAH ACJER ALKWR CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION 7T5 AGWNL H94 K9. 7X8 |
ID | FETCH-LOGICAL-c365t-450ae4d07f3faf7f0ad4a68dafb4cfc0e2ac25e88e5cca380cc8a500c54ab7c33 |
ISSN | 0961-2033 |
IngestDate | Sat Oct 05 05:29:11 EDT 2024 Thu Oct 10 18:08:26 EDT 2024 Thu Sep 12 18:09:53 EDT 2024 Sat Sep 28 08:25:39 EDT 2024 Tue Jul 16 20:51:39 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | immunoglobulin binding protein 1 lupus nephritis Systemic lupus erythematosus |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c365t-450ae4d07f3faf7f0ad4a68dafb4cfc0e2ac25e88e5cca380cc8a500c54ab7c33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-1189-7637 0000-0001-8722-3124 0000-0002-8029-7355 |
PMID | 32183589 |
PQID | 2394058610 |
PQPubID | 32637 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2378885445 proquest_journals_2394058610 crossref_primary_10_1177_0961203320912336 pubmed_primary_32183589 sage_journals_10_1177_0961203320912336 |
PublicationCentury | 2000 |
PublicationDate | 20200500 2020-05-00 20200501 |
PublicationDateYYYYMMDD | 2020-05-01 |
PublicationDate_xml | – month: 5 year: 2020 text: 20200500 |
PublicationDecade | 2020 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: England – name: London |
PublicationTitle | Lupus |
PublicationTitleAlternate | Lupus |
PublicationYear | 2020 |
Publisher | SAGE Publications Sage Publications Ltd |
Publisher_xml | – name: SAGE Publications – name: Sage Publications Ltd |
References | Nanahoshi, Tsujishita, Tokunaga 1999; 446 Juang, Wang, Jiang 2008; 181 Lee, Kwon, Ghang 2019; 20 Sule, Moodalbail, Burnham, Fivush, Furth 2015; 24 Katsiari, Kyttaris, Juang, Tsokos 2005; 115 Crispin, Apostolidis, Rosetti 2012; 188 Hahn, McMahon, Wilkinson 2012; 64 Bernatsky, Boivin, Joseph 2006; 54 Apostolidis, Rauen, Hedrich, Tsokos, Crispin 2013; 288 Hochberg 1997; 40 Fiehn, Hajjar, Mueller, Waldherr, Ho, Andrassy 2003; 62 Lisnevskaia, Murphy, Isenberg 2014; 384 Kuwahara, Matsuo, Nomura 1994; 152 Kwon, Lee, Ghang 2018; 48 Gladman, Ibanez, Urowitz 2002; 29 Habibzadeh, Habibzadeh, Yadollahie 2016; 26 Tenbrock, Juang, Kyttaris, Tsokos 2007; 46 Kong, Ditsworth, Lindsten, Thompson 2009; 36 Juang, Rauen, Wang 2011; 286 Safari, Baratloo, Elfil, Negida 2016; 4 Lee EJ (bibr11-0961203320912336) 2019; 20 bibr14-0961203320912336 bibr5-0961203320912336 bibr3-0961203320912336 Safari S (bibr16-0961203320912336) 2016; 4 bibr1-0961203320912336 bibr6-0961203320912336 bibr8-0961203320912336 bibr13-0961203320912336 Kuwahara K (bibr4-0961203320912336) 1994; 152 bibr19-0961203320912336 bibr17-0961203320912336 bibr15-0961203320912336 bibr9-0961203320912336 bibr2-0961203320912336 bibr10-0961203320912336 bibr7-0961203320912336 Gladman DD (bibr12-0961203320912336) 2002; 29 bibr20-0961203320912336 bibr18-0961203320912336 |
References_xml | – volume: 115 start-page: 3193 year: 2005 end-page: 3204 article-title: Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus publication-title: J Clin Invest contributor: fullname: Tsokos – volume: 24 start-page: 862 year: 2015 end-page: 868 article-title: Predictors of kidney disease in a cohort of pediatric patients with lupus publication-title: Lupus contributor: fullname: Furth – volume: 384 start-page: 1878 year: 2014 end-page: 1888 article-title: Systemic lupus erythematosus publication-title: Lancet contributor: fullname: Isenberg – volume: 152 start-page: 2742 year: 1994 end-page: 2752 article-title: Identification of a 52-kDa molecule (p52) coprecipitated with the Ig receptor-related MB-1 protein that is inducibly phosphorylated by the stimulation with phorbol myristate acetate publication-title: J Immunol contributor: fullname: Nomura – volume: 62 start-page: 435 year: 2003 end-page: 439 article-title: Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment publication-title: Ann Rheum Dis contributor: fullname: Andrassy – volume: 20 year: 2019 article-title: Immunoglobulin binding protein 1 as a potential urine biomarker in patients with lupus nephritis publication-title: Int J Mol Sci contributor: fullname: Ghang – volume: 181 start-page: 3658 year: 2008 end-page: 3664 article-title: PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells publication-title: J Immunol contributor: fullname: Jiang – volume: 40 start-page: 1725 year: 1997 article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum contributor: fullname: Hochberg – volume: 26 start-page: 297 year: 2016 end-page: 307 article-title: On determining the most appropriate test cut-off value: the case of tests with continuous results publication-title: Biochem Med (Zagreb contributor: fullname: Yadollahie – volume: 188 start-page: 3567 year: 2012 end-page: 3571 article-title: Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism publication-title: J Immunol contributor: fullname: Rosetti – volume: 48 start-page: 462 year: 2018 end-page: 466 article-title: Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus publication-title: Semin Arthritis Rheum contributor: fullname: Ghang – volume: 446 start-page: 108 year: 1999 end-page: 112 article-title: Alpha4 protein as a common regulator of type 2A-related serine/threonine protein phosphatases publication-title: FEBS Lett contributor: fullname: Tokunaga – volume: 64 start-page: 797 year: 2012 end-page: 808 article-title: American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis publication-title: Arthritis Care Res (Hoboken contributor: fullname: Wilkinson – volume: 54 start-page: 2550 year: 2006 end-page: 2557 article-title: Mortality in systemic lupus erythematosus publication-title: Arthritis Rheum contributor: fullname: Joseph – volume: 4 start-page: 111 year: 2016 end-page: 113 article-title: Evidence based emergency medicine; part 5 receiver operating curve and area under the curve. publication-title: Emerg (Tehran) contributor: fullname: Negida – volume: 286 start-page: 1795 year: 2011 end-page: 1801 article-title: Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus publication-title: J Biol Chem contributor: fullname: Wang – volume: 36 start-page: 51 year: 2009 end-page: 60 article-title: Alpha4 is an essential regulator of PP2A phosphatase activity publication-title: Mol Cell contributor: fullname: Thompson – volume: 46 start-page: 1525 year: 2007 end-page: 1530 article-title: Altered signal transduction in SLE T cells publication-title: Rheumatology (Oxford contributor: fullname: Tsokos – volume: 29 start-page: 288 year: 2002 end-page: 291 article-title: Systemic lupus erythematosus disease activity index 2000 publication-title: J Rheumatol contributor: fullname: Urowitz – volume: 288 start-page: 26775 year: 2013 end-page: 26784 article-title: Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling publication-title: J Biol Chem contributor: fullname: Crispin – ident: bibr19-0961203320912336 doi: 10.1016/j.semarthrit.2018.02.012 – ident: bibr5-0961203320912336 doi: 10.1016/j.molcel.2009.09.025 – volume: 4 start-page: 111 year: 2016 ident: bibr16-0961203320912336 publication-title: Emerg (Tehran) contributor: fullname: Safari S – ident: bibr8-0961203320912336 doi: 10.1074/jbc.M110.166785 – ident: bibr15-0961203320912336 doi: 10.11613/BM.2016.034 – ident: bibr20-0961203320912336 doi: 10.1177/0961203315570162 – ident: bibr10-0961203320912336 doi: 10.1093/rheumatology/kem154 – ident: bibr1-0961203320912336 doi: 10.1016/S0140-6736(14)60128-8 – ident: bibr18-0961203320912336 doi: 10.1074/jbc.M113.483743 – volume: 20 year: 2019 ident: bibr11-0961203320912336 publication-title: Int J Mol Sci contributor: fullname: Lee EJ – ident: bibr3-0961203320912336 doi: 10.1136/ard.62.5.435 – volume: 29 start-page: 288 year: 2002 ident: bibr12-0961203320912336 publication-title: J Rheumatol contributor: fullname: Gladman DD – volume: 152 start-page: 2742 year: 1994 ident: bibr4-0961203320912336 publication-title: J Immunol doi: 10.4049/jimmunol.152.6.2742 contributor: fullname: Kuwahara K – ident: bibr6-0961203320912336 doi: 10.1016/S0014-5793(99)00189-1 – ident: bibr7-0961203320912336 doi: 10.1172/JCI24895 – ident: bibr9-0961203320912336 doi: 10.4049/jimmunol.181.5.3658 – ident: bibr17-0961203320912336 doi: 10.4049/jimmunol.1200143 – ident: bibr2-0961203320912336 doi: 10.1002/art.21955 – ident: bibr14-0961203320912336 doi: 10.1002/acr.21664 – ident: bibr13-0961203320912336 doi: 10.1002/art.1780400928 |
SSID | ssj0003196 |
Score | 2.363423 |
Snippet | Objective
Urine levels of immunoglobulin binding protein 1 (IGBP1) are increased in patients with lupus nephritis (LN) compared with systemic lupus... Urine levels of immunoglobulin binding protein 1 (IGBP1) are increased in patients with lupus nephritis (LN) compared with systemic lupus erythematosus (SLE)... ObjectiveUrine levels of immunoglobulin binding protein 1 (IGBP1) are increased in patients with lupus nephritis (LN) compared with systemic lupus... |
SourceID | proquest crossref pubmed sage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 547 |
SubjectTerms | Adaptor Proteins, Signal Transducing - blood Adult Anti-DNA antibodies Biomarkers - blood Biopsy Disease Progression Enzyme-Linked Immunosorbent Assay Female Humans Immunoglobulins Longitudinal Studies Lupus Lupus nephritis Lupus Nephritis - blood Lupus Nephritis - diagnosis Male Middle Aged Molecular Chaperones - blood Nephritis Plasma Proportional Hazards Models Regression analysis Sensitivity and Specificity Systemic lupus erythematosus |
Title | Plasma immunoglobulin binding protein 1 as a predictor of development of lupus nephritis |
URI | https://journals.sagepub.com/doi/full/10.1177/0961203320912336 https://www.ncbi.nlm.nih.gov/pubmed/32183589 https://www.proquest.com/docview/2394058610 https://search.proquest.com/docview/2378885445 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdbCmMvY99z1w0NxmAP7hR9xPZjuyWEkLV7SCBvRpZlFrY6ZY0p7K_fnaTYTdJBNwzGkoMc9POdT6e73xHy3jBbJXDEVvUteqsKECmVxaWuqkTqBNSyi7Y4G4zncrJQi65Kn8suWRfH5veteSX_gyr0Aa6YJfsPyLaDQgdcA75wBoThfCeMv4Hpe4GZjhdNvUJqDxdWXix9poqjYIB2H2vJaGQDKJfookf7sOxihbD5s7lEolYLyCLH0U2LdYq3WrV87Tfpz7-7tISdaJ5hU8eTpnXbOofNZAnqqNvqH4cIYOj7YTYjBKcDZ12I37H1ilImSQzLny1NGnwXyz21qDyrZvjCKk8PvK-83fYx1qDhTAgOlgwX4hae7LPzfDSfTvPZcDG7Tw54kinVIwcnp19OR-1XGFVLty39aXfUbTNkb22xFdfnTI3ZY_IorBHoiQf8Cbln66fkwdcQBfGMLDzudBt3GnCnAXfap_qKatriTlcVvYE7Nh3utMX9OZmPhrPP4zhUyIiNGKh1LBXTVpYsqUSlQeKYLqUepCBohTQVyCHXhiubplaBpIqUGZNiCQyjpC4SI8QL0qtXtX1FKNjFzDIs95MJaQai4CXTqZApK4wSkkXk42bC8ktPhJL3N1zxO5MbkaPNjOZBXK5yLjJYHKRgrkfkXXsblBnuUOnarhr8DXpkkB8qIi89Eu3DBBrzKs0i8gGh6Qb-2784vMNjXpOH3et9RHrrX419A1bmungbXqg_cyN7TQ |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+immunoglobulin+binding+protein+1+as+a+predictor+of+development+of+lupus+nephritis&rft.jtitle=Lupus&rft.au=Kwon%2C+Oh+Chan&rft.au=Lee%2C+Eun-Ju&rft.au=Oh%2C+Ji+Seon&rft.au=Hong%2C+Seokchan&rft.date=2020-05-01&rft.eissn=1477-0962&rft.volume=29&rft.issue=6&rft.spage=547&rft.epage=553&rft_id=info:doi/10.1177%2F0961203320912336&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0961-2033&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0961-2033&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0961-2033&client=summon |